Evidence map›Paper›PMID 38546672›Full record

ArticleHaematologica2024

Benefit of phlebotomy and low-dose aspirin in the prevention of vascular events in patients with

Léa Boulnois, Margot Robles, Nada Maaziz, Bernard Aral, Martin Gauthier, Francis Duchene, Marie-Amélie Goujart, Betty Gardie, François Girodon

Open access · goldAbstract readLetterComment
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Léa BoulnoisPôle Biologie, CHU Dijon.
Margot RoblesOnco-Hématologie, Service de Médecine Interne, Maladies Infectieuses et Hématologie, CHT Gaston Bourret, Nouméa, Nouvelle-Calédonie.
Nada MaazizPôle Biologie, CHU Dijon.
Bernard AralPôle Biologie, CHU Dijon.
Martin GauthierService d'Hématologie, Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France; Centre Hospitalier Jean Rougier, Cahors.
Francis DucheneService de Médecine Interne, Hôpital Nord Franche Comté, Belfort Montbéliard.
Marie-Amélie GoujartService d'Hématologie Biologique, Laboratoire de Biologie Médicale, CHT Gaston Bourret, Nouméa, Nouvelle-Calédonie.
Betty GardieUniversité de Nantes, CNRS, INSERM, L'Institut du thorax, Nantes, France; Ecole Pratique des Hautes Etudes, EPHE, Université PSL, France; Laboratoire d'Excellence GR-Ex.
François GirodonPôle Biologie, CHU Dijon, France; Laboratoire d'Excellence GR-Ex, France; Inserm U1231, Université de Bourgogne, Dijon, France; Member of France Intergroupe Myeloprolifératifs (FIM). francois.girodon@chu-dijon.fr.
Centre Hospitalier Territorial de Nouvelle-Calédonie · NCCentre Hospitalier Universitaire de Toulouse · FRL'Hôpital Nord Franche-Comté · FRUniversité de Bourgogne · FRUniversité Paris Sciences et Lettres · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AspirinPhlebotomyAdultAgedFemaleHumansMaleMiddle AgedNew CaledoniaTreatment OutcomeAspirin

Identifiers

PMID38546672
PMCPMC11290533
OpenAlexW4393264861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.